company background image
8257

Genes Tech Group HoldingsSEHK:8257 Stock Report

Market Cap

HK$198.0m

7D

0%

1Y

-22.4%

Updated

27 Sep, 2021

Data

Company Financials
8257 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends2/6

8257 Overview

Genes Tech Group Holdings Company Limited, an investment holding company, operates as a turnkey solution provider and trades in used semiconductor manufacturing equipment (SME) and parts.

Price History & Performance

Summary of all time highs, changes and price drops for Genes Tech Group Holdings
Historical stock prices
Current Share PriceHK$0.20
52 Week HighHK$0.18
52 Week LowHK$0.40
Beta-0.28
1 Month Change-10.00%
3 Month Change-23.85%
1 Year Change-22.35%
3 Year Change-5.71%
5 Year Changen/a
Change since IPO-17.84%

Recent News & Updates

Shareholder Returns

8257HK SemiconductorHK Market
7D0%-1.5%-2.4%
1Y-22.4%50.3%9.1%

Return vs Industry: 8257 underperformed the Hong Kong Semiconductor industry which returned 50.3% over the past year.

Return vs Market: 8257 underperformed the Hong Kong Market which returned 9.1% over the past year.

Price Volatility

Is 8257's price volatile compared to industry and market?
8257 volatility
8257 Beta-0.28
Industry Beta0.77
Market Beta1

Stable Share Price: 8257 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 8257's weekly volatility has decreased from 13% to 5% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2009253Ming-Hsiang Yanghttps://www.genestech.com

Genes Tech Group Holdings Company Limited, an investment holding company, operates as a turnkey solution provider and trades in used semiconductor manufacturing equipment (SME) and parts. The company’s services include tool relocation, tool refurbishment, equipment module modification, repairmen, and parts supply of SME. It provides SME and parts, such as furnaces, clean tracks, and other semiconductor equipment used in semiconductor manufacturing process and wafer fabrication, which includes deposition, photoresist coating, and development; and manufactures and sells heating jackets.

Genes Tech Group Holdings Fundamentals Summary

How do Genes Tech Group Holdings's earnings and revenue compare to its market cap?
8257 fundamental statistics
Market CapNT$706.72m
Earnings (TTM)NT$94.88m
Revenue (TTM)NT$1.46b

7.4x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
8257 income statement (TTM)
RevenueNT$1.46b
Cost of RevenueNT$1.11b
Gross ProfitNT$355.49m
ExpensesNT$260.61m
EarningsNT$94.88m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.095
Gross Margin24.30%
Net Profit Margin6.48%
Debt/Equity Ratio82.1%

How did 8257 perform over the long term?

See historical performance and comparison

Dividends

6.0%

Current Dividend Yield

42%

Payout Ratio

Valuation

Is Genes Tech Group Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 8257 (HK$0.2) is trading below our estimate of fair value (HK$1)

Significantly Below Fair Value: 8257 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 8257 is good value based on its PE Ratio (7.4x) compared to the Hong Kong Semiconductor industry average (24.2x).

PE vs Market: 8257 is good value based on its PE Ratio (7.4x) compared to the Hong Kong market (9.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 8257's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 8257 is good value based on its PB Ratio (0.9x) compared to the HK Semiconductor industry average (2.2x).


Future Growth

How is Genes Tech Group Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.3%

Forecasted Semiconductors industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Genes Tech Group Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Genes Tech Group Holdings performed over the past 5 years?

36.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 8257 has high quality earnings.

Growing Profit Margin: 8257's current net profit margins (6.5%) are lower than last year (9.1%).


Past Earnings Growth Analysis

Earnings Trend: 8257's earnings have grown significantly by 36.8% per year over the past 5 years.

Accelerating Growth: 8257's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 8257 had negative earnings growth (-42.3%) over the past year, making it difficult to compare to the Semiconductor industry average (52%).


Return on Equity

High ROE: 8257's Return on Equity (11.6%) is considered low.


Financial Health

How is Genes Tech Group Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 8257's short term assets (NT$2.0B) exceed its short term liabilities (NT$1.4B).

Long Term Liabilities: 8257's short term assets (NT$2.0B) exceed its long term liabilities (NT$283.5M).


Debt to Equity History and Analysis

Debt Level: 8257's debt to equity ratio (82.1%) is considered high.

Reducing Debt: 8257's debt to equity ratio has reduced from 173.8% to 82.1% over the past 5 years.

Debt Coverage: 8257's debt is well covered by operating cash flow (27.8%).

Interest Coverage: 8257's interest payments on its debt are well covered by EBIT (11.4x coverage).


Balance Sheet


Dividend

What is Genes Tech Group Holdings's current dividend yield, its reliability and sustainability?

6.03%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 8257's dividend (6.03%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.28%).

High Dividend: 8257's dividend (6.03%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.84%).


Stability and Growth of Payments

Stable Dividend: 8257 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 8257's dividend payments have increased, but the company has only paid a dividend for 3 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (42.2%), 8257's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.0yrs

Average management tenure


CEO

Ming-Hsiang Yang (50 yo)

11.75yrs

Tenure

NT$5,210,000

Compensation

Mr. Ming-Hsiang Yang serves as Chairman of Genes Tech Group Holdings Company Limited and has been its Chief Executive Officer since December 2009. Prior to joining the Group, Mr. Yang worked in Chung Mei P...


CEO Compensation Analysis

Compensation vs Market: Ming-Hsiang's total compensation ($USD187.50K) is about average for companies of similar size in the Hong Kong market ($USD229.36K).

Compensation vs Earnings: Ming-Hsiang's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: 8257's management team is seasoned and experienced (7 years average tenure).


Board Members

Experienced Board: 8257's board of directors are considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Genes Tech Group Holdings Company Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Genes Tech Group Holdings Company Limited
  • Ticker: 8257
  • Exchange: SEHK
  • Founded: 2009
  • Industry: Semiconductor Equipment
  • Sector: Semiconductors
  • Market Cap: HK$198.000m
  • Shares outstanding: 1.00b
  • Website: https://www.genestech.com

Number of Employees


Location

  • Genes Tech Group Holdings Company Limited
  • No. 80, Baotai 3rd Road
  • Hsinchu County
  • Zhubei
  • 30244
  • Taiwan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/27 15:47
End of Day Share Price2021/09/27 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.